Login / Register
iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
News By Market
Top PlusOneCoin Posters
Data Tools >
Price & News Alerts
More Tools >
My Image Gallery
PLUS1 Info & Faucet
Medical - Drugs
Acusphere, Inc (ACUS)
Add ACUS Price Alert
Search This Board:
7/5/2021 6:36:13 PM
- Board type:
- Posts Today:
Today : Friday 20 January 2012
Acusphere, Inc. (ACUS.PK) today announced that its stockholders voted to approve the proposed 1-for-10 reverse stock split of the Company's common stock at its Special Meeting of Stockholders held today.
See post 749 for press release, also currently a sticky post.
End Update 01.20.2012
Proxy Notice Of Special Meeting Received via US Mail. Posted a sticky on some highlights, I can't find a link to it on the ACUS website but one can likely find it searching the SEC, maybe?
They are asking for a 1-10 reverse stock split. The proxy has lots of interesting stuff in it. Maybe someone can find a link to it and post it.......
End Update 12.23.2011
Another Letter to the Shareholders was issued yesterday and can be read as the first sticky post.
A line from the letter is:
"We have now arrived at an important juncture, and we need your support to help effect a reverse stock split to allow the Company to finance the completion of our strategic direction."
So a reverse split may be coming. I have lightened up on my own shares but as of now still hold some and may buy or sell more as the future unfolds.
End 12.20.2011 update.
Imagify was shot down by the FDA advisory panel a couple years ago ,give or take a little, I think it was 16-1, mainly because Imagify had not been tested against a placebo. They had run trials against the "Standard Of Care," Nuke testing.
On June 8th 2011 ACUS announced that Imagify has been granted a SPA by the FDA for an addtional phase III against a placebo.
Also on June 8th 2011 ACUS announced that they hoped to complete their work to the EU for an MMA application for Imagify in the 2nd half of 2011.
You can read about these latest developments here, and I will try to figure out how to make this post a sticky.
Since I-Hub did away with their spell checker I no longer run my posts through one, so I apoligize to those who may be offened by this fact, in advance.
End of 10.07.2011 update.
Imagify is a cardiovascular drug for the detection of coronary artery disease, the leading cause of death in the United States & Europe.
: On October 24, 2008, Acusphere, Inc. (the "Company") announced the signing of a definitive agreement with Cephalon, Inc. ("Cephalon") to provide $20 million in upfront financing by purchasing a $15 million senior secured convertible note and by paying a $5 million upfront fee for an exclusive worldwide license to AI-525, a preclinical-stage injectable formulation of celecoxib using Acusphere's proprietary Hydrophobic Drug Delivery System (HDDS?) technology. On July 7, 2004, Acusphere announced a $70 million partnership for European development and marketing rights to Nycomed. From this partnership, Acusphere has currently received $12 million in milestone payments. An additional $58 million in milestone payments are related to regulatory approvals and achievement of certain sales goals.
Market Potential & Competition
: The potential market in the US for Imagify is estimated to be roughly $2 billion annually. It is estimated that more than 10 million procedures are done each year in the U.S. to detect coronary artery disease. The leading procedure to detect coronary heart disease is nuclear stress testing, which costs roughly double the amount to implement, takes significantly more time to administer, and is arguably more harmful to the patient/environment.
: The FDA granted ACUS an Advisory Panel Meeting for Imagify on December 10th, 2008. The panel voted against recommendation by a vote of 16-1. The PDUFA date is set for February 28, 2009. On this date the FDA will decide whether or not they approve of the drug. The company is also working with Nycomed to submit its MAA filing in Europe.
: AI-850 is a Phase 1 clinical trial completed product candidate that utilizes hydrophobic drug delivery system to improve the dissolution rate of a cancer drug.
On March 31, Acusphere licensed the property rights to its Hydrophobic Drug Delivery System™ (HDDS) for oncology applications to Cephalon for $10 million. Per the last conference call, the company may choose to license out the HDDS system to other companies for other applications. (Oncology is only one of the potential applications.)
If you would like to listen to Acusphere's most current conference calls or presentations, please go to the following:
Current share count:
Authorized Common Stock: 250 million shares
Outstanding Common Stock: 49.51 million shares
Preferred Stock convertible to common: 25.2 million shares
Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and formulations of existing drugs using its proprietary porous microparticle technology in the United States. Its porous microparticle technology enables to control the size and porosity of particles, including nanoparticles and microparticles. The company develops products in the areas of cardiology, oncology, and asthma. Its lead product candidate Imagify, a cardiovascular drug, is in Phase 3 clinical development for the detection of coronary artery disease. The company?s products also include AI-850, a Phase 1 clinical trial completed product candidate that utilizes hydrophobic drug delivery system to improve the dissolution rate of a cancer drug; AI-128, a Phase 1 clinical study completed formulation of asthma drug. Acusphere was founded in 1993 and is headquartered in Watertown, Massachusetts.
ACUS Detailed Quote
Post New Msg
My Stocks (1)
Using dead Delaware companies for IPO search it
07/05/21 06:36:13 PM
04/09/20 05:01:47 PM
Strap on? Ill buy more when the
04/08/20 06:34:57 PM
I figured we would have six months to
01/29/20 01:31:40 PM
$ACUS: ROlllllllllingggggg... $0.05 going
01/29/20 12:30:49 PM
This low float shell could be good just
03/29/19 06:03:02 PM
Not scared shorts selling a few hundred shares
02/27/19 06:30:47 PM
Perfect candidate for merger. https://www.thepharmaletter.com/article/compass-th
02/24/19 12:46:49 PM
This has been groomed for success most likely
02/22/19 09:58:15 PM
The last one on the list was the
02/22/19 08:07:56 AM
I don't see any mention of acusphere anywhere
02/21/19 04:40:43 PM
As holders though we'd like them to stay public...
01/27/19 03:25:07 PM
Why have a ct order and not jusy
01/26/19 08:21:22 PM
01/23/19 01:51:01 PM
Fda trials still going on https://pubchem.ncbi.nlm.nih.gov/compound/Perfluorobut
01/23/19 08:05:59 AM
12/19/18 09:01:48 PM
Mcda? Will look into.
12/19/18 06:27:46 PM
Gotcha. I got into a super low float
12/19/18 03:29:07 PM
I picked up a few shares this week.
12/19/18 05:40:26 AM
Did you sell and take the gain or
12/18/18 10:05:52 PM
What is your opinion on Euro Tech Holdings
12/18/18 08:05:33 PM
I seen somewhere after 10 years they can
10/10/18 12:04:54 PM
09/07/18 10:13:48 AM
zon$x 2 shares in my opinion someone is
09/07/18 10:12:05 AM
I've never figured it out either. I see
09/06/18 09:32:37 PM
What do you think the one share sale
09/06/18 09:28:07 PM
When those 0001's take off one can make
08/22/18 01:32:35 PM
I actually bought txh@e instead of txh#d Like
08/21/18 09:07:17 PM
I'll have to look at it. Not too
08/13/18 09:25:15 AM
Can you tell what happened with TXH#d I
08/11/18 11:10:19 PM
The only true way to find out is
08/10/18 11:43:26 AM
Could be a while got to get interest
08/09/18 10:03:46 PM
This thing moves on air!
05/23/18 09:27:54 PM
05/14/18 01:50:31 PM
Low float money taker you buy it up
05/14/18 10:55:31 AM
Lets move tomorrow!
05/13/18 10:25:17 PM
Agree. Every day it is insanely thin to
05/11/18 10:05:24 PM
This could easy go to the sky ..just
05/11/18 05:26:51 PM
And a seller into the 045 bid.
05/10/18 02:35:34 PM
Not sure. Good money can be made if
05/10/18 11:49:14 AM
Wonder what needs to be done so people
05/09/18 08:35:08 PM
So far if you click on the 1
05/09/18 08:26:20 PM
05/09/18 01:17:23 PM
What Idiot sold to the 068 bid?? Unbelievable!
05/08/18 04:02:54 PM
No selling into the 068 bid. Good sign
05/08/18 03:09:11 PM
Don't sell into the .068 bid guys and
05/08/18 12:51:00 PM
21k to .25 now. 3 mm's bidding .05+
05/07/18 01:36:56 PM
05/07/18 10:06:17 AM
Agree. Any small buying volume and we go!
05/07/18 08:42:21 AM
ACUS $$$$ COULD HAVE A MASSIVE WEEK..SO THIN
05/07/18 12:35:30 AM
Post New Msg
My Stocks (1)
Get FREE PlusOneCoins!
© 2021 InvestorsHub.com, Inc.
Terms of Service
Advertise With Us
Market Vision (YouTube)
Stock Market 101
Investor Help Forum
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App